Search research articles
Contact Us
Filters
Showing results (91-100 of 268) with videos related to
Page
of 27
Sort By:
Neurology
|
July 26, 2015
Standard chemoradiation for glioblastoma results in progressive brain volume loss
Morgan J Prust, Kourosh Jafari-Khouzani, Jayashree Kalpathy-Cramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas
Catherine L Nutt, Rebecca A Betensky, Melissa A Brower, et al.
Radiology
|
September 24, 2024
Absolute Metabolite Quantification in Individuals with Glioma and Healthy Individuals Using Whole-Brain Three-dimensional MR Spectroscopic and Echo-planar Time-resolved Imaging
Mehran Baboli, Fuyixue Wang, Zijing Dong, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 21, 2011
T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients
Kyrre E Emblem, Atle Bjornerud, Kim Mouridsen, et al.
The Journal of Clinical Investigation
|
September 4, 2013
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
Ovidiu C Andronesi, Otto Rapalino, Elizabeth Gerstner, et al.
Radiology
|
January 8, 2020
Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas
Xianqi Li, Bernhard Strasser, Kourosh Jafari-Khouzani, et al.
Cancer Research
|
April 22, 2011
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma
Heisoog Kim, Ciprian Catana, Eva-Maria Ratai, et al.
Journal of Neuro-Oncology
|
December 29, 2011
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors
Samuel A Goldlust, Robert Cavaliere, Herbert B Newton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2003
BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma
Kristina M Braaten, Rebecca A Betensky, Laurence de Leval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2013
BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults
Andrew S Chi, Tracy T Batchelor, Daniel Yang, et al.
Page
of 27
Search research articles
Search
Showing results (91-100 of 268) with videos related to
Sort By:
Page
of 27
Neurology
|
July 26, 2015
Standard chemoradiation for glioblastoma results in progressive brain volume loss
Morgan J Prust, Kourosh Jafari-Khouzani, Jayashree Kalpathy-Cramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 25, 2005
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas
Catherine L Nutt, Rebecca A Betensky, Melissa A Brower, et al.
Radiology
|
September 24, 2024
Absolute Metabolite Quantification in Individuals with Glioma and Healthy Individuals Using Whole-Brain Three-dimensional MR Spectroscopic and Echo-planar Time-resolved Imaging
Mehran Baboli, Fuyixue Wang, Zijing Dong, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism
|
April 21, 2011
T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients
Kyrre E Emblem, Atle Bjornerud, Kim Mouridsen, et al.
The Journal of Clinical Investigation
|
September 4, 2013
Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate
Ovidiu C Andronesi, Otto Rapalino, Elizabeth Gerstner, et al.
Radiology
|
January 8, 2020
Super-Resolution Whole-Brain 3D MR Spectroscopic Imaging for Mapping D-2-Hydroxyglutarate and Tumor Metabolism in Isocitrate Dehydrogenase 1-mutated Human Gliomas
Xianqi Li, Bernhard Strasser, Kourosh Jafari-Khouzani, et al.
Cancer Research
|
April 22, 2011
Serial magnetic resonance spectroscopy reveals a direct metabolic effect of cediranib in glioblastoma
Heisoog Kim, Ciprian Catana, Eva-Maria Ratai, et al.
Journal of Neuro-Oncology
|
December 29, 2011
Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors
Samuel A Goldlust, Robert Cavaliere, Herbert B Newton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 13, 2003
BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma
Kristina M Braaten, Rebecca A Betensky, Laurence de Leval, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 3, 2013
BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults
Andrew S Chi, Tracy T Batchelor, Daniel Yang, et al.
Page
of 27